ClinicalTrials.gg

Rabies clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 115 studies for Rabies across more than 10 countries. 12 are recruiting or about to start. 111 of them are mainly about Rabies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16.

Status

Completed
83
Status unknown
10
Not yet recruiting
8
Active, not recruiting
6
Terminated
3
Recruiting
2

Phase

Phase 3
37
Phase 2
22
Phase 4
17
Phase 1
15
Early Phase 1
2

Where

China
35
United States
19
Thailand
15
Philippines
7
Germany
6
Pakistan
5

Who develops what

Add Rabies to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 12 programs from 7 companies, 10 with this as their studies’ main aim; 4 with a live phase 3 study; 3 primary completions in the next 12 months. Compare Sinovac Biotech and Sinopharm here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
Rabies VaccinesRecent, repeated
Evidence
  • NCT07055893 · Sinovac Biotech Co., Ltd · Phase 3 · live · comparator · “Verorab®” · registered May 2025
  • NCT07055295 · Sinovac Biotech Co., Ltd · Phase 3 · live · comparator · “Verorab®” · registered May 2025
  • NCT07055880 · Sinovac Biotech Co., Ltd · Phase 2 · live · comparator · “Verorab®” · registered May 2025
  • NCT05846568 · Chongqing Genrix Biopharmaceutical Co., Ltd · Phase 3 · background · “Rabies Vaccine” · registered Apr 2023
  • NCT04644484 · Synermore Biologics (Suzhou) Co., Ltd. · Phase 3 · background · “Rabies Vaccine” · registered Nov 2020
—24 studies

2 more in limited or earlier use — sign in to see them, free.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
Rabies Vaccine (Serum-free Vero Cell), Freeze-dried☆ Track1 live phase-3 study: NCT07055295Sinovac Biotech Co., Ltd
Rabies vaccinePhase 4 trial recorded☆ Track1 live phase-3 study: NCT07055893Sinovac Biotech Co., Ltd
Sinovac rabies vaccine☆ Track1 live phase-3 study: NCT07416110Sinovac Biotech Co., Ltd
Experimental Lyophilized Human Rabies Vaccine (Human Diploid Cell)☆ Track1 live phase-3 study: NCT07500207Changchun BCHT Biotechnology Co.

The 4 in phase 3 with the nearest primary completion, of 12 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (3)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 30 Dec 2026 est.Rabies Vaccine (Serum-free Vero Cell), Freeze-dried · Sinovac Biotech Co., Ltd · Phase 3 main aimvs Rabies VaccinesNCT07055295 Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen — primary endpoint: Proportion of participants achieving a RVNA titer ≥0.5 IU/mL · 390 enrolled
  • 30 Jan 2027 est.Rabies vaccine · Sinovac Biotech Co., Ltd · Phase 3 main aimadded to Rabies VaccinesNCT07055893 Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen — primary endpoint: Proportion of participants achieving a rabies virus neutralizing antibody (RVNA) titer ≥0.5 IU/mL · 390 enrolled
  • 30 Jun 2027 est.Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried · Liaoning Chengda Biotechnology CO., LTD · Phase 4 main aimNCT07932132 Immunogenicity and Safety of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Patients Infected With Human Immunodeficiency Virus (HIV) — primary endpoint: Seroconversion rate and geometric mean concentration (GMC) of rabies virus neutralizing antibodies at 14 days after completion of the full vaccination course · 160 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Rabies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

6studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Who these studies take

Of the 2 Rabies studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
AgeWomenMen
101 (50%)1 (50%)
181 (50%)1 (50%)
301 (50%)1 (50%)
401 (50%)1 (50%)
501 (50%)1 (50%)
650 (0%)0 (0%)
750 (0%)0 (0%)
850 (0%)0 (0%)

Across all 115 studies, recruiting or not: 67% stop at 75 or younger and 65% at 65; 50% take children; 0% are for women only and 1% for men only; 82% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rabies studies take

Of 22 phase 3 interventional studies under Rabies, half reached primary completion within 15 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 315 mo8–21 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 115. Browse all 115 → or search them.